维立志博-B(09887)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09887 维立志博-B

未开盘 07-28 16:09:10

73.300

+6.200

+9.24%

最高73.750	最低63.200	成交量493.27万
今开67.100	昨收67.100	日振幅15.72%
总市值141.47亿	流通市值108.48亿	总股本1.93亿
成交额3.41亿	换手率3.33%	流通股本1.48亿
市净率67.18	ROE--	每股收益-1.72
52周最高79.600	52周最低63.200	市盈率-42.49
股息0.00	股息收益率0.00	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"维立志博-B","latestPrice":73.3,"timestamp":1753690150628,"preClose":67.1,"halted":0,"volume":4932728,"delay":0,"floatShares":148000000,"shares":193000000,"eps":-1.725,"marketStatus":"未开盘","change":6.2,"latestTime":"07-28 16:09:10","open":67.1,"high":73.75,"low":63.2,"amount":341376572,"amplitude":0.157228,"askPrice":73.3,"askSize":17200,"bidPrice":73.25,"bidSize":2700,"shortable":0,"etf":0,"ttmEps":-1.651777067,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753752600000},"marketStatusCode":0,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":67.1,"openAndCloseTimeList":[[1753666200000,1753675200000],[1753678800000,1753689600000]],"volumeRatio":0.14894248476986002,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09887","defaultTab":"news","newsList":[{"id":"1155536094","title":"维立志博-B午后强势拉升！此前上市首日股价飙涨近92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155536094","media":"老虎资讯综合","labels":[],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155536094?lang=zh_cn&edition=full","pubTime":"2025-07-28 13:30","pubTimestamp":1753680607,"startTime":"0","endTime":"0","summary":"7月28日，$维立志博-B(09887)$午后强势拉升，现涨超6%，此前上市首日股价飙涨近92%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"维立志博-B午后强势拉升！此前上市首日股价飙涨近92%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":0},{"id":"1103432189","title":"异动解读 | 维立志博-B股价盘中大涨5.07%，IPO热度延续助推股价走高","url":"https://stock-news.laohu8.com/highlight/detail?id=1103432189","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103432189?lang=zh_cn&edition=full","pubTime":"2025-07-28 13:22","pubTimestamp":1753680151,"startTime":"0","endTime":"0","summary":"港股新上市公司维立志博-B今日盘中大涨5.07%，延续了其上市以来的强劲表现，引发市场广泛关注。据报道，维立志博上市当天股价一度飙升127%，收盘时仍保持91.7%的涨幅，每股报67.1港元，总市值达129.7亿港元。数据显示，维立志博的融资申购倍数超过3000倍，融资申购额高达3300亿港元，成为7月以来港股IPO中最受追捧的新股。维立志博此次IPO全球发售3686.25万股H股，最终定价为每股35港元，共募集资金12.9亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09887"],"gpt_icon":1},{"id":"2554071578","title":"开盘大涨107%：维立志博今日港股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2554071578","media":"谈思生物","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554071578?lang=zh_cn&edition=full","pubTime":"2025-07-26 15:01","pubTimestamp":1753513263,"startTime":"0","endTime":"0","summary":"2025.07.26本文字数：461，阅读时长大约1.16分钟导读：7月25日，维立志博港交所首秀飙涨一倍，市值冲140亿港元；PD-L1/4-1BB双抗LBL-024手握“突破疗法”，肺外神经内分泌瘤有望率先撞线，三抗ADC借NewCo出海。2025年7月25日，维立志博正式登陆港交所主板，挂牌首日高开107%，总市值一举冲破140亿港元大关。维立志博创立于2012年，其首发产品LBL-024属于PD-L1×4-1BB双特异性抗体。维立志博携手百凯医药共同推进多款抗体偶联新药项目，其CD3/CD19/BCMA三特异性抗体则借助NewCo模式扬帆出海。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726150353a4646952&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726150353a4646952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","HSCEI","09887"],"gpt_icon":1},{"id":"2554793748","title":"维立志博-B(09887)：独立非执行董事杜季柳获委任为提名委员会的成员","url":"https://stock-news.laohu8.com/highlight/detail?id=2554793748","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554793748?lang=zh_cn&edition=full","pubTime":"2025-07-25 22:40","pubTimestamp":1753454430,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维立志博-B(09887)发布公告，(i)独立非执行董事杜以龙先生不再为公司提名委员会的成员;及(ii)独立非执行董事杜季柳已获委任为提名委员会的成员，自上市日期起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322229.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09887"],"gpt_icon":0},{"id":"1135975303","title":"港股综述｜半导体板块逆势走强，华虹半导体涨超9%；维立志博-B首挂大涨近92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135975303","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135975303?lang=zh_cn&edition=full","pubTime":"2025-07-25 16:30","pubTimestamp":1753432200,"startTime":"0","endTime":"0","summary":"半导体板块逆势走强，$华虹半导体$涨超9%，$中芯国际$、$上海复旦$涨近5%；机构看好AI和国产化打开成长空间。新股$维立志博-B$首日大幅收涨91.7%；此前公开发售阶段维立志博-B获3494.78倍认购，一手中签率0.27%。海南自贸区板块回调，半导体板块逆势拉升7月25日，A股主要指数集体下跌，沪指跌0.33%报3593点，深证成指跌0.22%，创业板指跌0.23%。全市场超2700股下跌。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","HSI","01347","09887"],"gpt_icon":0},{"id":"2554066758","title":"港股午评：高位回调！恒指跌1.11%止步5连涨，科技股、金融股低迷","url":"https://stock-news.laohu8.com/highlight/detail?id=2554066758","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554066758?lang=zh_cn&edition=full","pubTime":"2025-07-25 12:00","pubTimestamp":1753416044,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["TCEHY","BABA","HSImain","00700","METmain","MCHmain","TSLL","MIUmain","LU0797268264.HKD","KSTmain","HSCEI","BIDU","81810","HSTECH","HTCD.SI","LU1956131251.USD","LU2226246903.HKD","MPNGY","09618","09887","07226","BK4581","01810","03086","02833","161032","89618","HXXD.SI","08496","09988","JD","XIACY","TTTN","TSYW.SI","LU0048597586.USD","LU1993786604.SGD","MHImain","BK4551","TSLA","ALBmain","YANG","HSI","03690","01024","513600","HMTD.SI","TCHmain","HHImain","81024"],"gpt_icon":0},{"id":"2554964337","title":"招银国际作为整体协调人、联席全球协调人助力维立志博IPO成功发行并在香港联交所主板挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2554964337","media":"招银国际","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554964337?lang=zh_cn&edition=full","pubTime":"2025-07-25 10:08","pubTimestamp":1753409286,"startTime":"0","endTime":"0","summary":"交易概述2025年7月25日，南京维立志博生物科技股份有限公司成功在香港联合交易所主板挂牌上市。招银国际担任维立志博在香港IPO的整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人。作为招商银行境外综合金融服务业务旗舰平台，招银国际融资实施“立足香港，深植内地，面向全球”的发展战略。招银国际融资已逐步成为香港资本市场最为活跃且增长力强劲的金融机构之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725113131a6c0c9e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725113131a6c0c9e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887"],"gpt_icon":1},{"id":"1128548340","title":"异动解读 | 维立志博-B首日挂牌大涨115.71%，创新药企IPO获3494倍超额认购","url":"https://stock-news.laohu8.com/highlight/detail?id=1128548340","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128548340?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:32","pubTimestamp":1753407158,"startTime":"0","endTime":"0","summary":"7月25日，创新药企维立志博-B在港交所主板挂牌上市，盘中大涨115.71%，引发市场广泛关注。该公司此前公开发售部分获3494.78倍超额认购，最终以每股35港元的上限价格定价，募集资金净额约11.79亿港元。维立志博是一家专注于肿瘤免疫疗法的临床阶段生物科技公司，致力于开发突破性癌症疗法。尽管维立志博上市首日表现亮眼，但作为尚未盈利的生物科技公司，其未来发展仍面临研发风险、激烈的市场竞争以及商业化挑战。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09887"],"gpt_icon":0},{"id":"2554734627","title":"港股早评：三大指数低开 金融股回调 有色金属股、水泥股强势","url":"https://stock-news.laohu8.com/highlight/detail?id=2554734627","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554734627?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:28","pubTimestamp":1753406899,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MHImain","89618","TCHmain","01299","09618","HSTECH","161715","KSTmain","MIUmain","165316","81299","159871","BABA","09696","ALBmain","01772","00700","HSI","MCHmain","600585","03086","YANG","TTTN","000819.SH","01810","07226","01024","600801","06655","HXXD.SI","002466","81810","03330","81024","HTCD.SI","02233","000979.SH","02833","002460","HHImain","HSImain","HSCEI","TCEHY","161032","BIDU","JD","09887","00914"],"gpt_icon":0},{"id":"2554734640","title":"“中国TCE第一股”在港交所挂牌上市，维立志博价值揭秘正当时","url":"https://stock-news.laohu8.com/highlight/detail?id=2554734640","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554734640?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:25","pubTimestamp":1753406700,"startTime":"0","endTime":"0","summary":"数据显示，上半年港股市场已完成35宗IPO项目，累计募资金额达959.29亿港元，较去年同期大幅增长758.8%，创下历史同期新高。值此之际，有着“中国TCE第一股”之称的维立志博于2025年7月25日在港交所主板正式挂牌上市，股票代码为09887。此次IPO，维立志博全球发售约3686万股股份，发售价为每股35港元，每手100股。日前，公司更是将TCE技术与ADC平台融合，推出创新产品LBL-058。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321772.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"“中国TCE第一股”在港交所挂牌上市，维立志博价值揭秘正当时","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09887"],"gpt_icon":1},{"id":"2554773464","title":"新股首日 | 维立志博-B(09887.HK)首挂上市 早盘高开近107% 核心产品LBL-024为处于注册临床试验阶段的4-1BB靶向候选药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2554773464","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554773464?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:24","pubTimestamp":1753406693,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03347","BK1141","BK1583","09887","BK1576"],"gpt_icon":0},{"id":"1197788615","title":"新股首日｜维立志博-B大幅高开逾106%，中签一手赚3740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197788615","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197788615?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:22","pubTimestamp":1753406530,"startTime":"0","endTime":"0","summary":"7月25日，$维立志博-B(09887)$首挂大幅高开逾106%，中签一手赚3740港元，总市值超136亿港元；此前公开发售阶段维立志博-B获3494.78倍认购，一手中签率0.27%，认购400手稳获一手。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":0},{"id":"1135478411","title":"新股定价 | 维立志博-B上限定价，公开发售超购3493倍，一手中签率0.27%、抽400手稳获一手","url":"https://stock-news.laohu8.com/highlight/detail?id=1135478411","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135478411?lang=zh_cn&edition=full","pubTime":"2025-07-25 07:21","pubTimestamp":1753399314,"startTime":"0","endTime":"0","summary":" $维立志博-B(09887)$ (09887)公布招股结果，上限定价35港元，集资总额约12.9亿港元，净额约11.79亿港元。每手100股，一手中签率0.27%，认购400手才可稳获一手。甲组尾至少获2手，头槌飞最多获16手。公开发售共接获323,706份有效申请，当中73,406份获受理，超购3,493.78倍，触发回拨机制，令发售比例升至43.48%。国际发售有141名承配人，超购39.78倍。维立志博今日（25日）挂牌。维立志博计划发行3205.4万股H股，一成于香港作公开发售，每股招股价介乎31.6至35元，集资最多11.2亿元。摩根士丹利、中信証券为联席保荐人。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/146b5ed11cb8a15915eed9fdbdf4b318","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/146b5ed11cb8a15915eed9fdbdf4b318"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"维立志博-B上限定价，公开发售超购3493倍，一手中签率0.27%、抽400手稳获一手","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":0},{"id":"2554735255","title":"港股IPO动态：今日维立志博上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2554735255","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554735255?lang=zh_cn&edition=full","pubTime":"2025-07-25 06:10","pubTimestamp":1753395031,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["09887"],"gpt_icon":0},{"id":"2553789617","title":"维立志博-B(09887.HK)最终每股发售价35港元 香港公开发售获3494.78倍认购","url":"https://stock-news.laohu8.com/highlight/detail?id=2553789617","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553789617?lang=zh_cn&edition=full","pubTime":"2025-07-24 22:46","pubTimestamp":1753368398,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09887"],"gpt_icon":0},{"id":"2553240201","title":"新股暗盘 | 维立志博-B(09887.HK)暗盘收涨100.14% 每手赚3505港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553240201","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553240201?lang=zh_cn&edition=full","pubTime":"2025-07-24 18:39","pubTimestamp":1753353586,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09887"],"gpt_icon":0},{"id":"2553277327","title":"新股暗盘 | 维立志博-B(09887)暗盘盘初涨超95% 每手赚3335港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553277327","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553277327?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:16","pubTimestamp":1753345018,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，维立志博-B(09887)将于7月25日(周五)在香港挂牌。截至发稿，暗盘交易显示报价68.35港元，较招股价35港元上涨95.29%，每手100股，不计手续费，每手赚3335港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09887"],"gpt_icon":0},{"id":"1194189978","title":"老虎暗盘｜维立志博-B飙涨100%，股价站上70港元！中签一手赚3500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194189978","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194189978?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:15","pubTimestamp":1753344946,"startTime":"0","endTime":"0","summary":"7月24日，生物科技公司$维立志博-B(09887)$暗盘开张40%，报48港元/股，总市值超76亿港元；不计手续费，中签一手赚1300港元；公司每股定价35港元，每手100股，将于7月25日（周五）正式挂牌交易。维立志博-B此前认购火爆，孖展超购逾3029倍，位于今年来新股认购倍数榜第5位；公司冻资近3400亿港元，同样位居今年来新股冻资榜第5位。","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":0},{"id":"1145589802","title":"维立志博-B认购火爆！孖展申购倍数近2400倍，申购额近2700亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145589802","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145589802?lang=zh_cn&edition=full","pubTime":"2025-07-21 18:00","pubTimestamp":1753092000,"startTime":"0","endTime":"0","summary":"7月21日，生物科技公司$维立志博-B$认购火爆！截止发稿，孖展申购倍数近2400倍，申购额近2700亿港元。此前该公司公告拟全球发售3205.44万股H股，其中，香港发售占10%，国际发售占90%。公司已与基石投资者LVC实体、高毅实体 、TruMed、OrbiMed、Huang River Investment Limited、易方达基金、Foresight Funds、Sage Partners及汉康实体订立基石投资协议，基石投资者已同意在若干条件的规限下，按发售价认购或促使其指定实体认购可购入有关数目的发售股份，总金额为6900万美元。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":1},{"id":"2552330444","title":"维立志博招股首日认购近179倍；奥克斯二度递表港交所丨港交所早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2552330444","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552330444?lang=zh_cn&edition=full","pubTime":"2025-07-18 00:30","pubTimestamp":1752769853,"startTime":"0","endTime":"0","summary":"｜2025年7月18日星期五｜NO.1维立志博招股首日认购近179倍7月17日，维立志博-B（HK02617）正式在港交所启动招股，招股截至7月22日，预计于7月25日在港交所挂牌上市。该公司专注于发现、开发和商业化治疗肿瘤、自身免疫性疾病以及其他严重疾病的新疗法。其招股价为31.6港元至35港元，拟全球发售3205.44万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507183460298531.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507183460298531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1258","BK1229","02080","09887"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.leadsbiolabs.com","stockEarnings":[{"period":"1week","weight":1.0943},{"period":"ytd","weight":1.0943}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0526},{"period":"3month","weight":0.1615},{"period":"6month","weight":0.2639},{"period":"1year","weight":0.5018},{"period":"ytd","weight":0.2743}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"南京维立志博生物科技股份有限公司是一家主要从事发现、开发和商业化治疗肿瘤、自身免疫性疾病以及其他严重疾病的新疗法的中国公司。该公司的主要候选药物包括LBL-024、LBL-034、LBL-033、LBL-007等。该公司的LBL-024主要用于治疗肺外神经内分泌癌（EP-NEC）、小细胞肺癌（SCLC）、胆道癌（BTC）及非小细胞肺癌（NSCLC）、食管鳞状细胞癌（ESCC）、肝细胞癌（HCC）、胃癌（GC）及其他实体瘤。该公司还开发了专有技术平台，包括LeadsBody平台（CD3 T-cell engager平台）、X-body平台（4-1BB engager平台）以及其他几个双特异性抗体及融合蛋白平台。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"维立志博-B","nameEN":"LEADS BIOLABS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维立志博-B(09887)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维立志博-B(09887)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维立志博-B,09887,维立志博-B股票,维立志博-B股票老虎,维立志博-B股票老虎国际,维立志博-B行情,维立志博-B股票行情,维立志博-B股价,维立志博-B股市,维立志博-B股票价格,维立志博-B股票交易,维立志博-B股票购买,维立志博-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维立志博-B(09887)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维立志博-B(09887)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}